SLEEP AIDS IN SOUTH AFRICA

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Sleep Aids the Smallest Category in Consumer Health As Prescription Medicines Dominate Sales

Urbanisation and Stressful Lifestyles Support Growth

Herbal/traditional Sleep Aids Benefit From Perceived Danger of Prescription Medicines

Competitive Landscape

Aspen Pharmacare Retains Its Leading Position in A Fragmented Category

Pfizer's Sleep Eze Pm Benefits From Dual Usage

Herbal/traditional Brands Subject To More Price Promotions

Category Data

Table 1 Sales of Sleep Aids: Value 2013-2018

Table 2 Sales of Sleep Aids: % Value Growth 2013-2018

Table 3 NBO Company Shares of Sleep Aids: % Value 2014-2018

Table 4 LBN Brand Shares of Sleep Aids: % Value 2015-2018

Table 5 Forecast Sales of Sleep Aids: Value 2018-2023

Table 6 Forecast Sales of Sleep Aids: % Value Growth 2018-2023

Executive Summary

Self-medication and Challenging Economic Climate Impact Growth

Uncertainty Persists Surrounding Amendments To the Complementary and Alternative Medicines (cams) Act

Adcock Ingram Maintains Its Leading Position While Private Label Is on the Rise

Chemists/pharmacies Remains the Leading Distribution Channel

Health and Wellness and Self-medication Trends Open Up New Opportunities for Consumer Health Players

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 8 Life Expectancy at Birth 2013-2018

Market Data

Table 9 Sales of Consumer Health by Category: Value 2013-2018

Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 14 Distribution of Consumer Health by Format: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format and Category: % Value 2018

Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Sources

Summary 1 Research Sources

OTC sleep aids remains the smallest category in consumer health in value terms in 2018. Despite the fact that OTC sleep aids are readily available in a range of channels, they are not perceived by consumers to be as effective as prescription medicines. Prescription medication is relatively accessible for middle- and high-income groups which have medical insurance. Consumers without medical insurance and on a limited budget, on the other hand, tend to resort to cheaper alternatives. The authoriti...

Euromonitor International's Sleep Aids in South Africa report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Sleep Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.